About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘wiley retractions’ Category

Déjà vu: Double pub in the same issue earns a retraction

with 7 comments

biomedchromAlways do a careful reading of your galleys, editors.

We imagine readers of Biomedical Chromatography’s special issue, “Reminiscences of Chang Kee Lim,” did some flipping back and forth when they found the same paper published twice.

Here’s the resulting notice for “Determination of 4-hydroxy-2-nonenal in serum by high-performance liquid chromatography with fluorescence detection after pre-column derivatization using 4-(N,N-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole”:  Read the rest of this entry »

About these ads

Written by Cat Ferguson

August 28, 2014 at 11:30 am

New method sinks newish paper…or does it?

with 4 comments

cover_2009_BB_viz_biomassThe timing on a recent retraction of a paper from Biotechnology and Bioengineering makes it a bit difficult to figure out what happened, but here’s a try.

An article first published online May 16th by a group of researchers at Brown University was retracted on June 1st, apparently because a new and better method for analyzing the data was developed…at some point.

The timeline is not exactly clear from the retraction, though we’ve reached out to the author and publisher and will update with any new information.

Here’s the (paywalled) notice for “High-level production of 3-hydroxypropionatein Escherichia coli and Saccharomyces cerevisiae by introducing part of the 3-hydroxypropionate/4-hydroxybutyrate cycle from Metallosphaera sedula”:

Read the rest of this entry »

Second study of widely touted cancer and HIV “cure” retracted

with 4 comments

j med virologyLast month, we brought you the story of the retraction of a paper by Nobutu Yamamoto and colleagues about “a protein being used — unapproved by health agencies — to treat diseases including cancer and autism.”

A second paper by the group, about using the protein to treat HIV, has been retracted. Here’s the notice for “Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF),” from the Journal of Medical Virology:
Read the rest of this entry »

Written by Ivan Oransky

August 21, 2014 at 4:00 pm

“Is Imitation the Sincerest Form of Flattery? Not Without Proper Attribution.”

with one comment

regional sci policy practiceWe’re going to get a little meta here, so be warned.

Take a look at the headline of this post. For those of you unfamiliar with the symbols to the left and right of the words, those are quotation marks. What that means is that we’ve taken those two sentences from another source. And here is that other source, a blog post from Tahseen Consulting titled — yes, you guessed it, “Is Imitation the Sincerest Form of Flattery? Not Without Proper Attribution.”

Apparently, the last group of authors who liked Tahseen’s words enough to use them did so without that whole attribution thing. Here, let us demonstrate attribution again, this time using the WordPress block-quote function. From the post: Read the rest of this entry »

Written by Ivan Oransky

August 12, 2014 at 11:00 am

Serial figure fakers have expression of concern upgraded to a retraction

with 7 comments

Another retraction has appeared up for frequent fliers Jun Li, Kailun Zhang and Jiahong Xia at Huazhong Science and Technology University in Wuhan, China.

We’ve covered them twice before, for a variety of retractions, corrections, and expressions of concern.

The retraction, in Clinical and Experimental Immunology, upgrades an expression of concern published earlier this year, and is the team’s fourth.

Here’s the notice for “CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice”: Read the rest of this entry »

Paper about widely touted but unapproved “cure” for cancer, autism retracted

with 11 comments

int j cancerA paper about a protein being used — unapproved by health agencies — to treat diseases including cancer and autism has been retracted.

Here’s the notice from the International Journal of Cancer about a 2007 paper purporting to show that the substance, GcMAF, is useful against breast cancer: Read the rest of this entry »

Accounting professor faked data for two studies, destroyed evidence: University report

with 19 comments

James Hunton, via Bentley University

James Hunton, via Bentley University

The Bentley University accounting professor whose retraction we first reported on in November 2012 fabricated the data behind two papers, a university investigation has concluded.

James E. Hunton, who resigned in December 2012: Read the rest of this entry »

Written by Ivan Oransky

July 22, 2014 at 7:00 am

Follow

Get every new post delivered to your Inbox.

Join 34,433 other followers